Literature DB >> 8984074

Galactosaemia--a controversial disorder. Screening & outcome. Ireland 1972-1992.

N Badawi1, S F Cahalane, M McDonald, P Mulhair, B Begi, A O'Donohue, E Naughten.   

Abstract

We reviewed 20 years (from 1972 to 1992) of screening for galactosaemia in Ireland. We looked at a small group of 32 patients followed up in the same centre since diagnosis. 1.2 million babies have been screened with 55 cases of classical galactosaemia and 7 Duarte Variants being detected. The frequency is thus, 1:23,000 and is increased among itinerants to 1:700. The mean age of diagnosis was 6.9 days with 41/62 cases symptomatic at the time. There were 9 deaths, 8 in the first 10 years, six of whom were itinerants. On follow up of the 32 children, who have attended Temple Street Hospital, 13/32 have no detectable complication. Nineteen show either one or a combination of cataracts, speech problems, tremors, abnormal FSH and or LH, delayed mental development and recurring infections. The screening test is the Bacterial Inhibition Assay with Beutler test, an original blood spot as confirmation in presumptive possible cases. The Beutler test is performed urgently in high risk situations. Five classical galactosaemics gave false negative results, 3 because of poor feeding, and two because of soya milk formulas. Screening prevented deaths as 7/84 siblings of our cases were unexpected infant deaths, all but one predating screening. Unexplained delay in screening undermines its effectiveness. Survival is enhanced by aggressive neonatal care. Symptoms are improved on commencing diet, with cataracts regressing. Complications did not correlate with the day of starting diet. Galactose-1-Phosphate and urinary galactitol levels did not correlate with complications, but slit lamp examination has proved a helpful index of adherence to diet. The mechanism of complications is unclear, and it is essential that current research should be aggressively pursued to explain mental deficiency in cases treated either pre-natally or early in post natal life.

Entities:  

Mesh:

Year:  1996        PMID: 8984074

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  7 in total

1.  Newborn screening.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2010-05

2.  Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment.

Authors:  K P Coss; P P Doran; C Owoeye; M B Codd; N Hamid; P D Mayne; E Crushell; I Knerr; A A Monavari; E P Treacy
Journal:  J Inherit Metab Dis       Date:  2012-07-03       Impact factor: 4.982

Review 3.  Appropriateness of newborn screening for classic galactosaemia: a systematic review.

Authors:  L Varela-Lema; L Paz-Valinas; G Atienza-Merino; R Zubizarreta-Alberdi; R Vizoso Villares; M López-García
Journal:  J Inherit Metab Dis       Date:  2016-04-26       Impact factor: 4.982

4.  Cross-sectional analysis of speech and cognitive performance in 32 patients with classic galactosemia.

Authors:  Björn Hoffmann; Udo Wendel; Susanne Schweitzer-Krantz
Journal:  J Inherit Metab Dis       Date:  2011-02-24       Impact factor: 4.982

5.  Communication of genetic information by other health professionals: the role of the genetic counsellor in specialist clinics.

Authors:  Rosie O'Shea; Anne Marie Murphy; Eileen Treacy; Sally Ann Lynch; Kathryn Thirlaway; Debby Lambert
Journal:  J Genet Couns       Date:  2011-01-06       Impact factor: 2.537

6.  Systematic Review and Meta-analysis of Intelligence Quotient in Early-Treated Individuals with Classical Galactosemia.

Authors:  Lindsey Welling; Susan E Waisbren; Kevin M Antshel; Hugh-Owen Colhoun; Matthias Gautschi; Stephanie Grünewald; Rebecca Holman; Johanna H van der Lee; Eileen P Treacy; Annet M Bosch
Journal:  JIMD Rep       Date:  2017-04-09

7.  Negative screening tests in classical galactosaemia caused by S135L homozygosity.

Authors:  E Crushell; J Chukwu; P Mayne; J Blatny; E P Treacy
Journal:  J Inherit Metab Dis       Date:  2009-05-08       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.